Sodium channel mutations in epilepsy and other neurological disorders

Journal of Clinical Investigation

Volumn 115, Issue 8, 2005, Pages 2010-2017

  Meisler, Miriam H ^a   Kearney, Jennifer A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHANNEL;

ATAXIA; EPILEPSY; GENE MUTATION; HUMAN; MENTAL DISEASE; MISSENSE MUTATION; NEUROLOGIC DISEASE; NOCICEPTION; PRIORITY JOURNAL; REVIEW; SEIZURE; SODIUM CURRENT;

ANIMALS; CHROMOSOMES, HUMAN; EPILEPSY; HUMANS; ION TRANSPORT; MENTAL DISORDERS; MICE; MUTATION; NERVOUS SYSTEM DISEASES; SODIUM CHANNELS;

EID: 23644439941     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI25466     Document Type: Review

References (88)

1. Jiang, V., et al. 2003. X-ray structure of a voltage-dependent K+ channel. Nature. 423:33-41.
2. Jiang, Y., Ruta, V., Chen, J., Lee, A., and MacKinnon, R. 2003. The principle of gating charge movement: in a voltage-dependent K+ channel. Nature. 423:42-48.
3. Isom, L.L., Dejongh, K.S., and Catterall, W.A. 1994. Auxiliary subunits of voltage-gated ion channels. Neuron. 12:1183-1194.
4. Yu, F.H., et al. 2003. Sodium channel β4, a new disulfide-linked auxiliary subunit with similarity to β2. J. Neurosci. 23:7577-7585.
5. Plummer, N.W., and Meisler, M.H. 1999. Evolution and diversity of mammalian sodium channel genes. Genomics. 57:323-331.
6. Goldin, A.L. 2001, Resurgence of sodium channel research. Annu. Rev. Pbysiol. 63:871-894.
7. Scheffer, I., and Berkovic, S.F. 1997. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenorypes. Brain. 120:479-490.
8. Singh, R., Scheffer, I.E., Crossland, K., and Berkovic, S.F. 1999. Generalized epilepsy with febrile seizures plus: a common childhood-onset genetic epilepsy syndrome. Ann. Neurol. 45:75-81.
9. Wallace, R., et al. 1998. Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel betal subunit gene SCN1B. Nat. Genet. 19:366-370.
10. Meadows, L.S., et al. 2002. Functional and biochemical analysis of a sodium channel beta 1 subunit mutation responsible for generalized epilepsy with febrile seizures plus type 1. J Neurosci. 22:10699-10709.
11. Audenaert, D., et al. 2003. A deletion in SCN1B is associated with febrile seizures and early-onset absence epilepsy. Neurology. 61:854-856.
12. Baulac, S., et al. 1999. A second locus for familial generalized epilepsy with febrile seizures plus maps to chromosome 2q21-q33. Am. J. Hum. Genet. 65:1078-1085.
13. Moulard, B., et al. 1999. Identification of a new locus for generalized epilepsy with febrile seizures plus (GEFS+) on chromosome 2q24-q33. Am. J. Hum. Genet. 65:1396-1400.
14. Escayg, A., et al. 2000. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat, Genet. 24:343-345.
15. Bonanni, P., et al. 2004. Generalized epilepsy with febrile seizures plus (GEFS+): clinical spectrum in seven Italian families unrelated to SCN1A, SCN1B, and GABRG2 gene mutations. Epilepsia. 45:149-158.
16. Abou-Khalil, B., et al. 2001. Partial and generalized epilepsy with febrile seizures plus and a novel SCN1A mutation. Neurology. 57:2265-2272.
17. Annesi, G., et al. 2003. Two novel SCN1A missense mutations in generalized epilepsy with febrile seizures plus. Epilepsia. 44:1257-1258.
18. Ceulemans, B.P., Claes, L.R., and Lagae, L.G. 2004. Clinical correlations of mutations in the SCN1A gene: from febrile seizures to severe myoclonic epilepsy in infancy. Pediatr. Neurol. 30:236-243.
19. Escayg, A., et al. 2001. A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plus -and prevalence of variants in patients with epilepsy. Am. J. Hum. Genet. 68:866-873.
20. Gerard, F., Pereira, S., Robaglia-Schlupp, A., Genton, P., and Szepetowski, P. 2002. Clinical and genetic analysis of a new multigenerational pedigree with GEFS+ (generalized epilepsy with febrile seizures plus). Epilepsia. 43:581-586.
21. Ito, M., et al. 2002. Autosomal dominant epilepsy with febrile seizures plus with missense mutations of the (Na+)-channel alpha 1 subunit gene, SCN1A. Epilepsy Res. 48:15-23.
22. Lerche, H., et al. 2001. Generalized epilepsy with febrile seizures plus: further heterogeneity in a large family. Neurology. 57:1191-1198.
23. Spampanato, J., et al. 2004. A novel epilepsy mutation in the sodium channel SCN1A identifies a cytoplasmic domain for beta subunit interaction. J. Neurosci. 24:10022-10034.
24. Sugawara, T., et al. 2001. Nav1.1 mutations cause febrile seizures associated with afebrile partial seizures. Neurology. 57:703-705.
25. Wallace, R.H., et al. 2001. Neuronal sodium-channel alpha1-subunit mutations in generated epilepsy with febrile seizures plus. Am. J. Hum. Genet. 68:859-865.
26. Claes, L., et al. 2001. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am. J. Hum. Genet. 68:1327-1332.
27. Wallace, R.H., et al. 2003. Sodium channel alpha1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms. Neurology. 61:765-769.
28. Fukuma, G., et al. 2004. Mutations of neuronal voltage-gated Na+ channel alpha1 subunit gene SCN1A in core severe myoclonic epilepsy in infancy (SMEI) and in borderline SMEI (SMEB). Epilepsia. 45:140-148.
29. Sugawara, T., et al. 2001. A missense mutation of the Na+ channel alpha II subunit gene Na(v)1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc. Natl. Acad. Sci. U. S. A. 98:6381-6389.
30. Kamiya, K., et al. 2004. A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline. J. Neurosci. 24:2690-2698.
31. Heron, S.E., et al. 2002. Sodium-channel defects in benign familial neonatal-infantile seizures. Lancet. 360:851-852.
32. Berkovic, S.F., et al. 2004. Benign familial neonatal-infantile seizures: characterization of a new sodium channelopachy. Ann. Neurol. 55:550-557.
33. Rhodes, T.H., Lossin, C., Vanoye, C.G., Wang, D.W., and George, A.L., Jr. 2004. Noninactivating voltage-gated sodium channels in severe myoclonic epilepsy of infancy. Proc. Natl. Acad. Sci. U. S. A. 101:11147-11152.
34. Yu, F.H., et al. 2004. Deletion of the Nav1.1 channel: a mouse model for severe myoclonic epilepsy of infancy. Program no. 479.5 presented at the 34th Annual Society for Neuroscience Meeting. October 25. San Diego, California, USA. http://sfn.scholar-one.com/itin2004/index.html.
35. Planells-Cases, R., et al. 2000. Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. Biophys. J. 78:2878-2891.
36. Trudeau, M.M., Dalton, J.D., Day, J.W., Ranum, L.P.W., and Meisler, M.H. 2004. Heterozygosity for a truncation allele of sodium channel SCN8A in a family with ataxia and cognitive impairment. Program no. 205 presented at the 54th Annual Meeting of the American Society of Human Genetics. October 30. Bethesda, Maryland, USA. http://www. ashg.org/genetics/ashg04s/index.shtml.
37. Chen, C., et al. 2002. Reduced sodium channel density, altered voltage dependence of inactivation, and increased susceptibility to seizures in mice lacking sodium channel beta 2-subunits. Proc. Natl. Acad. Sci. U. S. A. 99:17072-17077.
38. Chen, C., et al. 2004. Mice lacking sodium channel beta1 subunits display defects in neuronal excitability, sodium channel expression, and nodal architecture. J. Neurosci. 24:4030-4042.
39. Lossin, C., Wang, D.W., Rhodes, T.H., Vanoye, C.G., and George, A.L., Jr. 2002. Molecular basis of an inherited epilepsy. Neuron. 34:877-884.
40. Cossette, P., et al. 2003. Functional characterization of the D188V mutation in neuronal voltage-gated sodium channel causing generalized epilepsy with febrile seizures plus (GEFS). Epilepsy Res. 53:107-117.
41. Alekov, A., Rahman, M.M., Mitrovic, N., Lehmann-Horn, F., and Lerche, H. 2000. A sodium channel mutation causing epilepsy in man exhibits subtle defects in fast inactivation and activation in vitro. J. Physiol. 529:533-539.
42. Alekov, A.K., Rahman, M.M., Mitrovic, N., Lehmann-Horn, F., and Lerche, H. 2001. Enhanced inactivation and acceleration of activation of the sodium channel associated with epilepsy in man. Eur. J. Neurosci. 13:2171-2176.
43. Lossin, C., et al. 2003. Epilepsy-associated dysfunction in the voltage-gated neuronal sodium channel SCN1A. J. Neurosci. 23:11289-11295.
44. Sugawara, T., et al. 2003. Nav1.1 channels with mutations of severe myoclonic epilepsy in infancy display attenuated currents. Epilepsy Res. 54:201-207.
45. Spampanato, J., Escayg, A., Meisler, M.H., and Goldin, A.L. 2001. Functional effects of two voltage-gated sodium channel mutations that cause generalized epilepsy with febrile seizures plus type 2. J. Neurosci. 21:7481-7490.
46. Spampanato, J., Escayg, A., Meisler, M.H., and Goldin, A.L. 2003. Generalized epilepsy with febrile seizures plus type 2 mutation W1204R alters voltage-dependent gating of Nav1.1 sodium channels. Neuroscience. 116:37-48.
47. Ohmori, I., Ouchida, M., Ohtsuka, Y., Oka, E., and Shimizu, K. 2002. Significant correlation of the SCN1A mutations and severe myoclonic epilepsy in infancy. Biochem. Biophys. Res. Commun. 295:17-23.
48. Kearney, J.A., et al. 2001. A gain-of-function mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities. Neuroscience. 102:307-317.
49. Smith, M.R., and Goldin, A.L. 1997. Interaction between the sodium channel inactivation linker and domain III S4-S5. Biophys. J. 73:1885-1895.
50. Abriel, H., Wehrens, X.H.T., Benhorin, J., Kerem, B., and Kass, R.S. 2000. Molecular pharmacology of the sodium channel mutation D 1790G linked to the long-QT syndrome. Circulation. 102:921-925.
51. Benhorin, J., et al. 2000. Effects of flecainide in patients with new SCN5A mutation: mutation-specific therapy for long-QT syndrome? Circulation. 101:1698-1706.
52. Tate, S.K., et al. 2005. Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin. Proc. Natl. Acad. Sci. U. S. A. 102:5507-5512.
53. Gennaro, E., et al. 2003. Familial severe myoclonic epilepsy of infancy: truncation of Nav1.1 and genetic heterogeneity. Epileptic Disord. 5:21-25.
54. Fujiwara, T., et al. 2003. Mutations of sodium channel α subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures. Brain. 126:531-546.
55. Weiss, K.M. 2005. Cryptic causation of human disease: reading between the (germ) lines. Trends Genet. 21:82-88.
56. Legare, M.E., Bartlett, F.S., 2nd, and Frankel, W.N. 2000. A major effect QTL determined by multiple genes in epileptic EL mice. Genome Res. 10:42-48.
57. Schauwecker, P.E., Williams, R.W., and Santos, J.B. 2004. Genetic control of sensitivity to hippocampal cell death induced by kainic acid: a quantitative trait loci analysis. J. Comp. Neurol. 477:96-107.
58. Ferraro, T.N., et al. 2004. Fine mapping of a seizure susceptibility locus on mouse chromosome 1: nomination of Kcnj10 as a causative gene. Mamm. Genome. 15:239-251.
59. Ferraro, T.N., et al. 1999. Mapping loci for pentylenetetrazol-induced seizure susceptibility in mice. J. Neurosci. 19:6733-6739.
60. Bergren, S.K., Chen, S., Galecki, A., and Kearney, J.A. 2005. Genetic modifiers affecting severity of epilepsy caused by mutation of sodium channel Scn2a. Mamm. Genome. In press.
61. Buchner, D.A., Trudeau, M., and Meisler, M.H. 2003. SCNM1, a putative RNA splicing factor that modifies disease severity in mice. Science. 301:967-969.
62. Meisler, M.H., Kearney, J., Escayg, A., MacDonald, B.T., and Sprunger, L.K. 2001. Sodium channels and neurological disease: insights from Scn8a mutations in the mouse. Neuroscientist. 7:136-145.
63. v1.6) in cerebellar Purkinje and granule cells. Program no. 397.1 presented at the Annual Society for Neuroscience Meeting. October 23-27. San Diego, California, USA. http://sfn.scholarone. com/itin2004/index.html.
64. Levin, S.I., and Meisler, M.H. 2004. Floxed allele for conditional inactivation of the voltage-gated sodium channel Scn8a (NaV1.6). Genesis. 39:234-239.
65. Wood, J.N., Boorman, J.P., Okuse, K., and Baker, M.D. 2004. Voltage-gated sodium channels and pain pathways. J. Neurobiol. 61:55-71.
66. Yang, Y., et al. 2004. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J. Med. Genet. 41:171-174.
67. Cummins, T.R., Dib-Hajj, S.D., and Waxman, S.G. 2004. Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy. J. Neurosci. 24:8232-8236.
68. v1.7 in familial erythromelalgia induces bursting of sensory neurons. Brain. doi:10.1093/brain/awh514.
69. Fertleman, C.R., Rees, M., Parker, K.A., Barlow, E., and Gardiner, R.M. 2004. Identification of the gene underlying an inherited disorder of pain sensation. Program no. 197 presented at the 54th Annual Meeting of the American Society of Human Genetics. October 26-30. Bechesda, Maryland, USA. http://www.ashg.org/genecics/ashg04s/index.shtml.
70. Nassar, M.A., et al. 2004, Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. Proc. Natl. Acad. Sci. U. S. A. 101:12706-12711.
71. Weiss, L.A., et al. 2003. Sodium channels SCN1A, SCN2A and SCN3A in familial autism. Mol. Psychiatry. 8:186-194.
72. Kim, J., et al. 2004. Calmodulin mediates Ca2+ sensitivity of sodium channels. J. Biol. Chem. 279:45004-45012.
73. Splawski, I., et al. 2004. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119:19-31.
74. Wasserman, D., Geijer, T., Rozanov, V., and Wasserman, J. 2005. Suicide attempt and basic mechanisms in neural conduction: relationships to the SCN8A and VAMP4 genes. Am. J. Med. Genet. B Neuropsychiatr. Genet. 133:116-119.
75. Do, M.T., and Bean, B.P. 2004. Sodium currents in subthalamic nucleus neurons from Nav1.6-null mice. J. Neurophysiol. 92:726-733.
76. Maurice, N., Tkatch, T., Meisler, M., Sprunger, L.K., and Surmeier, D.J. 2001. D1/D5 dopamine receptor activation differentially modulates rapidly inactivating and persistent sodium currents in prefrontal cortex pyramidal neurons. J. Neurosci. 21:2268-2277.
77. Raman, I.M., Sprunger, L.K., Meisler, M.H., and Bean, B.P. 1997. Altered subthreshold sodium currents and disrupted firing patterns in Purkinje neurons of Scn8a mutant mice. Neuron. 19:881-891.
78. Yan, H., Yuan, W., Velculescu, V.E., Vogelstein, B., and Kinzler, K.W. 2002. Allelic variation in human gene expression. Science. 297:1143.
79. Claes, L., et al. 2003. De novo SCN1A mutations are a major cause of severe myoclonic epilepsy of infancy. Hum. Mutat. 21:615-621.
80. Guerrini, R., and Aicardi, J. 2003. Epileptic encephalopathies with myoclonic seizures in infants and children (severe myoclonic epilepsy and myoclonic-astatic epilepsy). J. Clin. Neurophysiol. 20:449-461.
81. Nabbout, R., et al. 2003. Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy. Neurology. 60:1961-1967.
82. Oguni, H., et al. 2005. Severe myoclonic epilepsy in infancy: clinical analysis and relation to SCN1A mutations in a Japanese cohort. Adv. Neurol. 95:103-117.
83. Ohmori, I., et al. 2003. Is phenotype difference in severe myoclonic epilepsy in infancy related to SCN1A mutations? Brain Dev. 25:488-493.
84. Sugawara, T., et al. 2002, Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy. Neurology. 58:1122-1124.
85. Spampanato, J., Aradi, I., Soltesz, I., and Goldin, A.L. 2004. Increased neuronal firing in computer simulations of sodium channel mutations chat cause generalized epilepsy with febrile seizures plus. J. Neurophysiol. 91:2040-2050.
86. Kohrman, D.C., Smith, M.R., Goldin, A.L., Harris J., and Meisler, M.H. 1996. A missense mutation in the sodium channel Scn8a is responsible for cerebellar ataxia in the mouse mutant jolting. J. Neurosci. 16:5993-5999.
87. Kearney, J.A., et al. 2002. Molecular and pathological effects of a modifier gene on deficiency of the sodium channel Scn8a (Na(v)1.6). Hum. Mol. Genet. 11:2765-2775.
88. Akopian, A.N., et al. 1999. The tetrodoroxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat. Neurosci. 2:541-548.